Global Point-Of-Care Hba1c Testing Market, By Product (Instruments And Consumables), Technology (ION– Exchange HPCL, Enzymatic Assay, Affinity Binding Chromatography, Turbidimatric Inhibition Immunoassay), End-Users (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest Of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest Of Asia- Pacific, Brazil, Argentina, Rest Of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest Of Middle East And Africa) Industry Trends And Forecast To 2028
Market Analysis and Insights: Global Point-of-Care Hba1c Testing Market
Data Bridge Market Research analyses that the Point-of-care Hab1c testing market to account USD 833.06 million by 2028 and growing at a CAGR of 5.59% in the forecast period of 2021-2028.
Point-of-care Hab1c testing shows the level of glucose for the period of last 2 to 3 months. It is also called as A1c test. A diabetic patient need to take this test on regular basis to maintain their levels in range.
Surge in the adoption of minimally invasive properties growing number of patients suffering from cardiovascular diseases with lung disorders are the major factors that will influence the growth of Point-of-care Hab1c testing market. Furthermore, growing use of video-assisted surgical systems coupled with the energy based devices and high volume of facilities established for easy use and implementation of cardiac rhythm management devices are the driving factor accelerating the growth of the Point-of-care Hab1c testing market Rising innovations and adoption of advanced technologies for detecting and checking the levels of glucose in patients will further provide beneficial opportunities for the market growth.
However, lack of skilled professionals and complications associated with diabetes such as heart attack stroke kidney failure coma and others will obstruct the market growth. Lack of awareness about these risk and complications will challenge the market of the Point-of-care Hab1c testing.
This Point-of-care Hab1c testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point-of-care Hab1c testing devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point-of-care Hab1c Testing Market Scope and Market Size
The Point-of-care Hab1c testing market is segmented on the basis of product, technology and end user and hospitals, clinics, ambulatory surgery centre, homes and others end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, point-of-care Hab1c testing market is segmented into instruments and consumables.
The technology-based segment of the point-of-care HbA1c testing market is segmented into enzymatic assay, ion-exchange HPLC, and TINIA among others
- On the basis of end-user, the point-of-care Hab1c testing market is segmented into hospitals, clinics, ambulatory surgery centre, homes and others.
Point-of-care Hab1c testing market Country Level Analysis
Point-of-care Hab1c testing market is analysed and market size insights and trends are provided by country, product, technology and end-user as referenced above.
The countries covered in point-of-care Hab1c testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point-of-care Hab1c testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness about Hab1c testing changing lifestyle, and increasing population in this region.
The country section of the point-of-care Hab1c testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The point-of-care Hab1c testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care Hab1c testing market devices, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care Hab1c testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point-of-care Hab1c testing Market Share Analysis
The point-of-care Hab1c testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point-of-care Hab1c testing market.
The major players covered in the point-of-care Hab1c testing market report are Bio Rad laboratories,Inc. , Arkray INC, A menarini group,F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH , Hemocue Ab, Trinity Biotech , Pts Digonstic, Siemens healthcare gmbh, Alera inc, Danaher, Sugentech,Tech inc, Getein biotech I.N.C, Bio Merieux India Pvt ltd, EKF Diagnostic, other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-